Workflow Services, a comprehensive and automated platform that solves point-of-care clinical service delivery for pharmacies, announced a new partnership with Uh-Oh Labs, an NIH-funded diagnostics and health tech company.
Workflow Services creates streamlined digital processes and decision support tools to help pharmacists perform services, such as administering point-of-care tests and writing prescriptions, while remaining compliant with federal and state regulations.
"Through our partnership with UOL, pharmacy customers have greater access to PCR-quality tests, paired with point-of-care operational support from Workflow Services," said Kevin Houlihan, CEO of Workflow Services. "Customers also benefit from greater efficiency and the ability to scale point-of-care testing programs, enabling higher-margin services that unlock revenue and deliver benefits to stakeholders across the value chain."
Point-of-care testing organizations are required to report all COVID test results to health authorities within 24 hours. Every UOL test includes an automated reporting platform to fulfill these requirements. Organizations administering POC testing with automated reporting show increased efficiency, cutting time it takes to conduct test nearly in half. This speed and efficiency are crucial in test-to-treat scenarios where COVID prescriptions must be taken within five days of developing symptoms. UOL's COVID test eliminates the need for lab processing, allowing for both faster diagnosis and prescription writing and fulfillment—all handled seamlessly on the backend for the pharmacist.
"We know that automated reporting can save organizations administering point-of-care testing 50% of the time it takes to conduct tests," said UOL president and chief business offer, Alex Jiao. "Instead of making marginal returns by sending sample collections to labs, pharmacy customers can now be empowered to receive a higher return by owning the testing fully within their store."
Additionally, UOL is developing unique tests for flu, STIs and other critical health diagnostics, creating a precedent for point-of-care testing beyond COVID testing.